Is Akebia Therapeutics, Inc. AKBA stock halal to invest in?

No, as of February 2026, Akebia Therapeutics, Inc. stock (AKBA) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Akebia Therapeutics, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Akebia Therapeutics, Inc. and alternative halal stock options within the Tabadulat app.

How often is Akebia Therapeutics, Inc. AKBA reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Akebia Therapeutics, Inc. AKBA monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Akebia Therapeutics, Inc. AKBA pass the AAOIFI Non Permissible Income criteria?

Yes, as of February 2026, Akebia Therapeutics, Inc. stock (AKBA) passes the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources, such as interest, is below the acceptable threshold set by AAOIFI.

Does Akebia Therapeutics, Inc. AKBA pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Akebia Therapeutics, Inc. stock (AKBA) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

No, as of February 2026, Akebia Therapeutics, Inc. stock (AKBA) does not pass the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

English

العربية

كن أول من يعرف

انضم إلى قائمة الانتظار لدينا للوصول المبكر والحصري إلى منصة تداول تبادلات المتوافقة مع الشريعة الإسلامية. احصل على إشعار عند إطلاق المنصة وابدأ الاستثمار بثقة.

Akebia Therapeutics, Inc.

NASDAQ

متوافق مع الشريعة

ليست الشريعة

AKBA

About

Akebia Therapeutics, Inc.

AKBA

Akebia Therapeutics Inc. is a biopharmaceutical company that focuses on the development and commercialization of therapies for patients with kidney disease. It leverages its expertise in kidney disease biology to advance its pipeline of innovative therapies aimed at treating conditions such as chronic kidney disease (CKD). The company's lead product, vadadustat, is designed to simulate the body's response to reduced oxygen levels, providing an oral treatment for anemia due to CKD. Akebia's operations encompass both the development and partnership aspects, collaborating with academic institutions and pharmaceutical companies to maximize the impact of its therapies. Headquartered in Cambridge, Massachusetts, Akebia plays a significant role in the healthcare sector by addressing unmet medical needs in nephrology. The company's commitment to improving patient lives through scientific innovation positions it as a significant player in the biopharmaceutical landscape.

القطاع:

Healthcare

الصناعة:

Drug Manufacturers - Specialty & Generic

الموظفون:

181

الموقع الإلكتروني:

https://www.akebia.com

AKBA

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Akebia Therapeutics, Inc.

About

Akebia Therapeutics, Inc.

AKBA

Frequently asked questions

Is Akebia Therapeutics, Inc. AKBA stock halal to invest in?

How often is Akebia Therapeutics, Inc. AKBA reviewed for Shariah compliance?

Does Akebia Therapeutics, Inc. AKBA pass the AAOIFI Non Permissible Income criteria?

Does Akebia Therapeutics, Inc. AKBA pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Akebia Therapeutics, Inc. AKBA stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.